FOXH Foxhollow Technologies (MM)

REDWOOD CITY, Calif., May 17 /PRNewswire-FirstCall/ -- FoxHollow Technologies (NASDAQ:FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral and coronary artery disease, is scheduled to participate in the Citigroup Global Healthcare Conference on Thursday, May 24, 2007, in New York City. Matt Ferguson, chief financial officer, will provide an update on the company at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). A live audio webcast of the presentation will be available via the Internet at http://investor.foxhollowtech.com/ and will be available for replay for approximately three months. About FoxHollow Technologies FoxHollow Technologies, Inc. develops and markets minimally invasive devices for the removal of plaque and thrombus for the treatment of peripheral artery disease (PAD). PAD results from plaque that accumulates in the arteries and blocks blood flow in the legs. These blockages can result in severe pain for patients and very limited physical mobility. The company's SilverHawk Plaque Excision System is a minimally invasive method of removing the obstructive plaque and restoring blood flow to the legs and feet. The company's Rinspirator thrombectomy system removes thrombus, or blood clots, from occluded arteries in patients suffering from PAD or coronary artery disease (CAD). For more information, please visit our website at http://www.foxhollowtech.com/. Contacts Investor Relations: Matt Ferguson Chief Financial Officer 650-421-8449 Media Relations: Robin Gaffney 650-421-8614 DATASOURCE: FoxHollow Technologies CONTACT: Investors, Matt Ferguson, Chief Financial Officer, +1-650-421-8449, , or Media, Robin Gaffney, +1-650-421-8614, , both of FoxHollow Technologies Web site: http://www.foxhollowtech.com/

Copyright